Proving Our Worth: HBCUs, STEM Partnerships and the Marginalization of Black Women in Industry Settings
The Review of Higher Education · 2025-12
DOI: 10.1353/rhe.0.a976793 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Review of Higher Education, 2025-12. Verfasst von Krystal L. Williams und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
University-industry partnerships (UIPs) in STEM expand opportunities for students and incorporate industry experiences into the academic enterprise. While UIPs have increased, few studies explore marginalized students’ experiences within industry settings. Our study addresses this literature gap with an emphasis on Black women in computing from HBCUs. We utilized the Role Strain and Adaptation Model for Black Women’s STEM Success and phenomenological approaches to explore challenges that many Black women encounter in UIPs—specifically structural inequities at the intersection of race and gender; macroaggressions and imposter syndrome. Implications for practice, research, and policy are discussed while noting increasingly complicated climates for diversity efforts.
Zitieren
APA
Williams, K. L., Dillon, E., Jones, J., Carter, S., Walker, W., & Melchior, S. (2025). Proving Our Worth: HBCUs, STEM Partnerships and the Marginalization of Black Women in Industry Settings. The Review of Higher Education. https://doi.org/10.1353/rhe.0.a976793
Vancouver
Williams KL, Dillon E, Jones J, Carter S, Walker W, Melchior S. Proving Our Worth: HBCUs, STEM Partnerships and the Marginalization of Black Women in Industry Settings. The Review of Higher Education. 2025. doi:10.1353/rhe.0.a976793
BibTeX
@article{Williams2025,
author = {Williams, Krystal L. and Dillon, Edward and Jones, Janelle and Carter, Shanice and Walker, William and Melchior, Shelly},
title = {Proving Our Worth: HBCUs, STEM Partnerships and the Marginalization of Black Women in Industry Settings},
journal = {The Review of Higher Education},
year = {2025},
doi = {10.1353/rhe.0.a976793}
}
EUVIMED